Create an account to read this article
You need to create an account to read this article.
Create Account Sign in
Nephrology
Diabetes and Endocrinology
Cardiology and CTVS
Medicine
Empagliflozin Reduces Risk Of Disease Progression And Death In High-Risk CKD Patients: NEJM
0 Comments
Post a comment
No comments yet. Be the first to comment!